Use of AR-Based Warfarin Management App in Valve Replacement Patient. Nonrheumatic mitral valve disorders
Conditions
Interventions
Intervention 1: Intervention group: Eligible heart valve replacement patients, after being introduced to the researcher and providing informed consent, will be enrolled in the intervention group. On t
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: First-time heart valve replacement Use of warfarin Minimum literacy (ability to read) Having normal vision and hearing ability Owning a smartphone Proficiency in the Persian language Age between 18 and 60 years No history of psychological disorders, as reported by the patient’s family
Exclusion criteria
Exclusion criteria: Patients with cognitive or psychological impairments Patients with severe liver or kidney diseases that significantly affect warfarin metabolism • Patients who change their treatment or medication during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-Efficacy. Timepoint: At the beginning of the study and at the sixth week after surgery. Method of measurement: Self-Efficacy for Managing Chronic Disease – 6 Item Scale.;INR Control. Timepoint: The first three days after surgery, and the fourth and sixth weeks after surgery. Method of measurement: TTR (Time in Therapeutic Range).;Treatment Adherence. Timepoint: At the beginning of the study and at the sixth week after surgery. Method of measurement: General Medication Adherence Scale-GMAS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarjes Yaghoubi
Mashhad University of Medical Sciences
Outcome results
None listed